Skip to main content
. 2021 Mar 26;13(7):1532. doi: 10.3390/cancers13071532

Table 1.

Autoimmune cytopenias (AICy) complicating lymphoproliferative disorders.

AICy Lymphoproliferative Disorder Frequency of AICy Key Findings References
AIHA CLL 7 to 15% The commonest AICy correlating with advanced disease and high biologic risk (del 11q, del17p, unmutated IGHV) [1,11]
NHL 2 to 50% Frequency is maximal in angioimmunoblastic T-cell lymphoma and in marginal zone lymphoma [5,12]
HL 0.2% Very rare association, but may increase after HSCT or therapy with CPIs. [4,5,13,14]
LGLL Case reports May be concomitant, precede or follow LGL diagnosis; may be concomitant to ITP and AIN and be multi-refractory (even require splenectomy) [15]
CD Case reports to 6% May revert after anti-IL6 therapy with tocilizumab [16]
ALL Case reports Mainly B-ALL in the pediatric setting and post-HSCT [17]
MM Case reports May rarely complicate MM and also precede the diagnosis. [18]
ITP CLL 1 to 5% Even in association with AIHA (ES). Difficult to distinguish from infiltrative cytopenia; response to steroids and IVIG may confirm the diagnosis [11]
NHL Case reports Mainly in Waldenström macroglobulinemia and marginal zone NHL; may also follow fludarabine treatment and HSCT. [12]
HL 0.2 to 1% May precede or follow HL diagnosis and be observed even after remission; ITP risk may increase after HSCT or CPIs. [13,14,19]
LGLL 1 to 20% May respond to steroids, IVIG and cytotoxic immunosuppressants used for LGL [20]
CD Case reports Case reports of ITP and ES during CD progression, may respond to rituximab or be refractory [21]
ALL Case reports Mostly during chemotherapy. Some require more than 3 lines including splenectomy [22]
MM Case reports MM may be complicated by ITP and ES; lenalidomide may increase the risk. [23,24]
AA/PRCA/AIN CLL <1% AIN has been reported in only 3 out of 1750 patients (0.17%); anti-neutrophil autoantibodies may be positive [11]
NHL Case reports Up to 21 cases of PRCA and rarely AA reported; may develop at onset, during remission, or after chemotherapy and/or HSCT; may be associated with EBV infection and AIHA [12]
HL Case reports 16 patients reported in literature. Case reports of AIN, even years after remission, successfully treated with IVIG [14,25]
LGLL Case reports Three patients with concomitant amegakaryocytic thrombocytopenia and PRCA and 1 with concomitant AIHA, ITP and AIN [26]
ALL Case reports Two patients with T-ALL developed PRCA, possibly associated with ALL therapy; 1 patient with T-lymphoblastic lymphoma presented as AA and hypercalcemia [27]
MM Case report Association of AIN and anti-thyroid autoantibodies [28]

AIHA autoimmune hemolytic anemia, ITP immune thrombocytopenia, AA aplastic anemia, PRCA pure red cell aplasia, AIN autoimmune neutropenia, CLL chronic lymphocytic leukemia, NHL non-Hodgkin lymphoma, HL Hodgkin lymphoma, LGLL large granular lymphocyte leukemia, CD Castleman disease, ALL acute lymphoblastic leukemia, MM multiple myeloma; HSCT hematopoietic stem cell transplant; CPIs checkpoint inhibitors, ES, Evans syndrome, IVIG intravenous immunoglobulins, EBV Epstein Barr virus.